{"id":"https://openalex.org/W4387954775","doi":"https://doi.org/10.1159/000534023","title":"Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report","display_name":"Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report","publication_year":2023,"publication_date":"2023-10-26","ids":{"openalex":"https://openalex.org/W4387954775","doi":"https://doi.org/10.1159/000534023","pmid":"https://pubmed.ncbi.nlm.nih.gov/38130896","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10735734"},"language":"en","primary_location":{"id":"doi:10.1159/000534023","doi":"https://doi.org/10.1159/000534023","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000534023","pdf_url":null,"source":{"id":"https://openalex.org/S62365728","display_name":"Case Reports in Oncology","issn_l":"1662-6575","issn":["1662-6575"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Reports in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1159/000534023","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109649864","display_name":"ALYSSA CRUSE","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alyssa R. Cruse","raw_affiliation_strings":["Department of Internal Medicine, Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037284385","display_name":"Alexa J. Basilio","orcid":"https://orcid.org/0000-0003-3872-0508","observed_orcids":["https://orcid.org/0000-0003-3872-0508"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexa J. Basilio","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056670989","display_name":"David H. Lawson","orcid":"https://orcid.org/0000-0002-9474-8321","observed_orcids":["https://orcid.org/0000-0002-9474-8321"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David H. Lawson","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109649864"],"corresponding_institution_ids":["https://openalex.org/I150468666"],"apc_list":{"value":1170,"currency":"USD","value_usd":1170},"apc_paid":{"value":1170,"currency":"USD","value_usd":1170},"fwci":0.4813,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.59079451,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"16","issue":"1","first_page":"1232","last_page":"1236"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.8830000162124634},{"id":"https://openalex.org/keywords/hypersensitivity","display_name":"hypersensitivity","score":0.8130000233650208},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.8410000205039978},{"id":"https://openalex.org/keywords/drug-intolerance","display_name":"drug intolerance","score":0.550000011920929}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9397268891334534},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.9346910715103149},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9093527793884277},{"id":"https://openalex.org/C2778300832","wikidata":"https://www.wikidata.org/wiki/Q1589604","display_name":"Premedication","level":2,"score":0.6308592557907104},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.5575107932090759},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5564278364181519},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5327971577644348},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5158061981201172},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4775719940662384},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42636430263519287},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4259146451950073},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.32339054346084595},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.22303393483161926},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2140149474143982},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.13538292050361633}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1159/000534023","doi":"https://doi.org/10.1159/000534023","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000534023","pdf_url":null,"source":{"id":"https://openalex.org/S62365728","display_name":"Case Reports in Oncology","issn_l":"1662-6575","issn":["1662-6575"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Reports in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10735734","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10735734","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10735734/pdf/cro-2023-0016-0001-534023.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Rep Oncol","raw_type":"Text"},{"id":"pmid:38130896","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38130896","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case reports in oncology","raw_type":"Case Reports"},{"id":"pmh:oai:doaj.org/article:81a7ee773b724b4abc580d0c83eb3c38","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/81a7ee773b724b4abc580d0c83eb3c38","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Case Reports in Oncology, Vol 16, Iss 1, Pp 1232-1236 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1159/000534023","doi":"https://doi.org/10.1159/000534023","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000534023","pdf_url":null,"source":{"id":"https://openalex.org/S62365728","display_name":"Case Reports in Oncology","issn_l":"1662-6575","issn":["1662-6575"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Reports in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387954775.pdf","grobid_xml":"https://content.openalex.org/works/W4387954775.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W2166662937","https://openalex.org/W2572174216","https://openalex.org/W2726507447","https://openalex.org/W2810967006","https://openalex.org/W2915708315","https://openalex.org/W2981068483","https://openalex.org/W3211668275","https://openalex.org/W4223507847","https://openalex.org/W4315701757"],"related_works":["https://openalex.org/W3108267351","https://openalex.org/W2913202470","https://openalex.org/W2272044596","https://openalex.org/W2954578306","https://openalex.org/W2957956603","https://openalex.org/W2737682594","https://openalex.org/W2981068483","https://openalex.org/W2347127875","https://openalex.org/W2510540636","https://openalex.org/W2800695190"],"abstract_inverted_index":{"Programmed":[0],"death":[1],"protein-1":[2],"(PD-1)":[3],"checkpoint":[4,73],"inhibitors":[5],"such":[6],"as":[7],"pembrolizumab":[8],"and":[9,17,26],"nivolumab":[10,49],"are":[11,19],"cornerstones":[12],"to":[13,22,31,48,54,75],"metastatic":[14,88],"melanoma":[15],"treatment,":[16],"they":[18],"often":[20],"considered":[21],"be":[23],"pharmacologically":[24],"similar":[25],"interchangeable":[27],"when":[28,60],"it":[29],"comes":[30],"designing":[32],"chemotherapy":[33],"regimens.":[34],"In":[35],"this":[36],"case":[37,65],"report,":[38],"we":[39],"describe":[40],"a":[41,67,83],"patient":[42,84],"who":[43],"had":[44],"consistent":[45],"immune":[46],"reactions":[47,81],"infusion":[50],"but":[51],"was":[52],"able":[53],"tolerate":[55],"pembrolizumab,":[56],"without":[57],"any":[58],"reactions,":[59],"given":[61],"hydrocortisone":[62],"premedication.":[63],"This":[64],"demonstrates":[66],"successful":[68],"transition":[69],"from":[70],"one":[71],"PD-1":[72],"inhibitor":[74],"another":[76],"with":[77],"resolution":[78],"of":[79],"infusion-related":[80],"in":[82],"undergoing":[85],"treatment":[86],"for":[87],"melanoma.":[89]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-10-27T00:00:00"}